# Grace Therapeutics, Inc.: Form 10-Q/A for the period ended Dec 31, 2024

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 10-Q/A
- Filed: 2025-02-19
- Accepted by EDGAR: Feb 18, 2025, 20:25 ET
- Period: 2024-12-31
- Accession: 0001140361-25-005051
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125005051/ef20043829_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036125005051/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036125005051/ef20043829_10qa.htm

Filed Feb 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-005051. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
